VAERS reports by lot

GSK Varicella/Shingles lot 5Z5LX: VAERS reports

20 VAERS reports list lot 5Z5LX as a GSK Varicella/Shingles vaccine, received between 2018-01-03 and 2018-10-09. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
20
Reports
5%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2835%
General / Systemic (non-local)2734%
Neurological911%
Allergic / Anaphylactic45%
Dermatological (non-injection-site)45%
Musculoskeletal34%
Gastrointestinal23%
Respiratory11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

North Carolina3
Wisconsin2
California1
Oregon1
Pennsylvania1
Florida1
Kansas1
Hawaii1
Washington1
Virginia1
Texas1
Oklahoma1

Reports by month received

2018-011
2018-021
2018-034
2018-044
2018-054
2018-063
2018-072
2018-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.